CpG island methylation is an important mechanism in gene silencing and is a key epigenetic event in cancer development. As yet, the number and identities of the genes that are inactivated in cancer cells has not been determined. In order to address this issue, we have performed a comprehensive isolation of CpG islands that are methylated in human lung adenocarcinomas. We have isolated approximately 200 CpG islands that are methylated in tumor DNA including those of known tumor-associated genes such as the HOXA5 gene. As the library contains the CpG islands of a number of known tumor suppressor genes it is highly likely that additional, previously unidenti®ed tumor suppressor genes, will be present. On average, 1 ± 2% of CpG islands were methylated speci®cally in tumors although this ®gure diered greatly between patients. This study provides an important resource in the search for genes inactivated in tumors and for the investigation of epigenetic dysregulation of gene expression by CpG island methylation.
Introduction
Accumulating evidence suggests that both genetic and epigenetic events play important roles in carcinogenesis. Genetic events include alterations in nucleotide sequence that may result in changes in the structure and therefore function of a gene product. Epigenetic changes are less well characterized but are known to produce alterations in gene regulation, chromatin structure, and other events that are not attributed to alterations of nucleotide sequence. DNA methylation is an important epigenetic event and is known to regulate gene expression and other biological phenomena (Bird, 2002) .
CpG islands are chromosomal regions, often located at the 5' region of genes, which have a high density of nonmethylated CpG sequences (Bird, 1986) . In nonCpG-island sites of the human genome most cytosine residues at CpG dinucleotides are methylated and this methylation status is stably maintained. However in cancer cells there is an altered CpG methylation pattern which is not always stably maintained. In addition, hypomethylation at CpG sequences is a general feature of tumor DNA, although in the DNA of cancer cells some CpG dinucleotides within CpG islands of certain genes are known to be methylated. Aberrant de novo methylation events at speci®c CpG islands are frequently observed in tumor DNA and have been reported to play a key role in the inactivation of many tumor suppressor genes .
Transcriptional repression is not the sole event mediated by methylation of CpG islands. CpG islands represent a model for active chromatin (Tazi and ) and methylation of CpG islands is associated with altered chromatin structure (Antequera et al., 1990) . It is reported that CpG islands are initiation sites for both transcription and DNA replication (Delgado et al., 1998) . The methylated CpG island of the HPRT gene on inactive X chromosomes is not only associated with transcriptional inactivation but also late replication of the gene (Schmidt and Migeon, 1990) . When the cell is treated with demethylating agent 5-aza-2'-deoxycytidine, the inactive allele became activated and shifts to an early replication state (Schmidt and Migeon, 1990) . These and other ®ndings strongly suggest that CpG islands are critical regions that regulate a number of cellular events.
In the study of cancer, the comprehensive isolation of genes inactivated by CpG island methylation is of great importance for the identi®cation of novel tumor suppressor genes and also in understanding epigenetic dysregulation of genome function. Approaches previously described for the isolation of CpG islands methylated in cancer have been based on fragmentation of DNA by restriction endonucleases in which digestion is dependent on the methylation status of the recognition sites (Shiraishi et al., 2000; 2002 in press).
However, a potential caveat of this type of approach is that it is not clear whether the methylation status of speci®c restriction sites within a CpG island represents that of the entire region of the CpG island. Furthermore, the PCR step in the isolation procedure adopted by many groups results in the loss of sequences that are resistant to ampli®cation, as is often the case with G+C-rich sequences.
We have previously described the combined use of two techniques, methyl-CpG binding domain (MBD) column chromatography and segregation of partly melted molecules (SPM), to isolate DNA fragments derived from CpG islands methylated in cancer cells (Shiraishi et al., 1999a) . Fractionation of DNA fragments by MBD column chromatography depends primarily on the number of methyl-CpG (mCpG) sites within the fragment (Cross et al., 1994; Shiraishi et al., 1999a) . The preferential isolation of DNA fragments derived from CpG islands by the SPM method is based on the principle that DNA fragments derived from G+C-rich regions have a reduced rate of strand dissociation during denaturing gradient gel electrophoresis (Shiraishi et al., 1995 (Shiraishi et al., , 1998 . DNA fragments derived from CpG islands are preferentially retained in the gel after prolonged electric ®eld exposure while others disappear following strand dissociation (Shiraishi et al., 1995 (Shiraishi et al., , 1998 . Both experimental results and calculations have shown that greater than 90% of CpG islands can be recovered by the SPM method (Shiraishi et al., 1995 (Shiraishi et al., , 1998 . In this study we have applied SPM and MBD chromatography for the comprehensive isolation of methylated CpG islands in human lung adenocarcinomas to identify potential tumor suppressor genes and also to understand epigenetic events in the cancer process.
Results

Comprehensive isolation of methylated CpG islands
Tsp509 I digests of tumor-derived DNA were subjected to three rounds of MBD column chromatography to enrich for methylated DNA. The highly methylated fragments were then cloned using a l vector (Shiraishi et al., 1999a) . Unexpectedly, 96% of clones in the methylated DNA library had short DNA inserts, most of which were not associated with CpG islands (Shiraishi et al., 1999a,b) . CpG islands can be of variable length. However, on the basis of nucleotide sequence, the size of most CpG islands is predicted to be greater than 300 bp (Larsen et al., 1992) . Therefore, in this study, we have focused on CpG-rich regions that are greater than 300 bp in length and eliminated all other sequences. The above procedure is summarized in Figure 1 .
Preliminary analysis revealed that 20% of the clones contained DNA fragments derived from the nontranscribed spacer region of the ribosomal RNA genes (positions 18956 ± 19358 of U13369, data not shown). A similar high representation of the clones containing DNA fragments derived from the nontranscribed spacer region of the ribosomal RNA genes has been also reported when highly methylated fragments derived from normal blood DNA were enriched by MBD column chromatography and cloned (Brock et al., 1999) . To exclude these clones, we performed PCR using primers speci®c for ribosomal RNA genes, and a DNA template from bacterial colonies that had been transformed with the plasmid clones. Bacterial colonies that produced a PCR product were subsequently eliminated.
Ultimately 6000 clones were sequenced, and using an algorithm that predicts the position of candidate CpG islands, approximately 1300 clones were identi®ed as having features of CpG islands. After allowing for redundancy of clones, 660 independent sequences were identi®ed as candidate CpG islands methylated in human lung adenocarcinomas. In the latter stages of sequencing, many clones were found to be identical to those we had previously sequenced suggesting that the majority of the highly represented clones in the library had been identi®ed.
Selection of DNA fragments corresponding to regions of CpG islands
To identify which of the isolated DNA fragments are derived from CpG islands, the methylation status of the corresponding genomic sequences was determined in normal somatic tissue DNA. As discussed earlier, MBD column chromatography separates DNA fragments from nonmethylated CpG islands predominantly into a low salt fraction (L) and those from highly methylated CpG islands into a high salt fraction (H) (Shiraishi et al., 1999a) . Tsp509 I digests of normal somatic tissue DNA were subjected to MBD column chromatography and DNA fragments corresponding to cloned DNAs were detected by PCR. Representative results are shown in Figure 2a . PCR-ampli®ed genomic DNA corresponding to the SPM fragment derived from CpG island B2254 was predominantly detected in fraction L suggesting that the genomic sequence is not methylated. Therefore based on the nucleotide sequence of this region and that it is non-methylated, this sequence can be regarded as a CpG island. All DNA sequences whose PCR products were present predominantly in the L fraction were classi®ed as Class I sequences, and in total 80% of CpG islands were assigned to this category (data not shown). Bisul®te genomic sequencing revealed that all of the analysed Class I sequences were methylation free in the predicted CpG island region (data not shown). Genomic DNA sequences whose PCR products were detected in H as observed in B1035 (Class II, PCR products both in L and H) and B353 (Class III, PCR products predominantly in H) ( Figure 2a) were not examined as to the presence of cancer-speci®c methylation. Bisul®te genomic sequencing of Class II and Class III sequences revealed heterogeneous methylation patterns in that some sequences were highly methylated but only at one end, whereas other sequences were evenly methylated throughout the fragment (Shiraishi et al., 2001) . We also identi®ed some sequences that were methylated at one allele and methylation-free at the other allele (Shiraishi et al., 2001) .
During our investigation we found that some DNA fragments from biallelically unmethylated CpG islands could also be fractionated in H. This occurred primarily when a large proportion of the fragment consisted of non-island sequence (Shiraishi et al., 2001) .
The identification of CpG islands that are methylated in cancer
The majority of SPM fragments in our study were derived from CpG islands and corresponded to genomic sequences reported in public databases. Therefore the corresponding genomic CpG island could be identi®ed and we were able to determine the methylation status of all Class I sequences in the DNA from patients used in the construction of the methylated DNA library. Representative results are shown in Figure 2b . PCR-ampli®ed DNA representing CpG island B2254 was detected in the High salt fraction in DNA from the Cancerous portion (CH) of lung tissue of patients 44 and 56, but not in the High salt fraction of DNA from the Noncancerous portion of lung (NH) tissue. This result indicates that in these patients CpG island B2254 is methylated speci®cally in tumors. In patients 108 and 113, DNA fragments corresponding to CpG island B2254 was detected in NH as well as CH. This suggests that de novo methylation of the island occurred in noncancerous as well as cancerous regions of lung tissue, however this CpG island was unmethylated in cancer DNA from patient 59. DNA fragments corresponding to CpG island B1847 were observed speci®cally in CH of patients 56, 59, 108, and 113. Bisul®te genomic sequencing was performed to con®rm the methylation status of the sequences described above. The SPM fragment corresponding to CpG island B2254 is derived from a 298 bp Tsp509 I fragment (positions 17 056 ± 17 353, AC004080), has 27 CpG sites and is located at the 5' region of the HOXA5 gene. When the methylation status of 22 of the CpG sites were analysed they were found to be nonmethylated in normal somatic tissue DNA (MaN, Figure 3 ). The presence of sequence variations (G/T at position 17 219, G/C at position 17 282, AC004080) in the fragment enabled the two alleles to be discriminated and we could therefore ascertain that in patients 108 and 113 both alleles are methylated in C, as well as in N, DNA samples. The SPM fragment corresponding to CpG island B1847 is derived from a Tsp509 I fragment which is 676 bp in length (positions 51 553 ± 52 228, AL035562) and has 49 CpG sites. This CpG island is located at the 3' region of the PAX1 gene. When the methylation status of 26 of the 49 CpG sites in the fragment was analysed in patients 108, 113, and 120, the presence of a highly methylated allele was con®rmed ( Figure 4) . However, the methylation pro®les diered between patients and since there were no genetic polymorphisms in the analysed sequence, we could not determine whether methylation was an allelic or nonallelic event, or alternatively whether the presence of a non-methylated allele was due to contamination with DNA from noncancerous cells.
Methylation patterns of isolated CpG islands in tumor DNAs are shown in Table 1 . Three CpG islands (B2361, B2737 and B5504) were methylated in all patients. The number of methylated CpG islands diered greatly between patients. In patient 44, 13% of the isolated CpG islands were methylated while in contrast 76% were methylated in patient 116.
Investigation of a potential association between methylation status and transcriptional repression
We next investigated the potential relationship between CpG island methylation and gene silencing. MBD column chromatography and RT ± PCR were used to determine methylation status, and gene expression, respectively. Representative results for CpG island B754 (located at the 5' region of the NID2 gene) are shown in Figure 5 . In cell lines A549, RERF-LC-OK, and RERF-LC-MS, CpG island B754 was unmethylated or weakly methylated, and the associated gene was expressed. In contrast, in cell lines ABC-1 and VMRC-LCD, CpG island B754 was methylated and a transcript could not be detected. In cell line LC-2/ad, the CpG island was unmethylated, but the transcript was not detected. CpG island B5279 corresponding to the 5' region of the TCF15 gene was not methylated in cell lines RERF-LC-MS and VMRC-LCD, and the gene was expressed. In cell lines A549, RERF-LC-OK, and LC-2/ad, this CpG island was methylated, but the Note not all Tsp509 I sites are indicated. Open and closed circles indicate nonmethylated and methylated CpG's, respectively. Letters (A to G) to the left of circles indicate the seven independent plasmid DNA clones that were sequenced. Horizontal bars at CpG site #3 indicate absence of CpG sequence due to sequence variation transcript was only detected in RERF-LC-OK. In cell line ABC-1, only a methylated CpG island was observed and the transcript was not detected. We con®rmed that the genes are reactivated by treatment with 5-aza-2'-deoxycytidine and histone deacetylase inhibitor trichostatin A (unpublished results). In each reaction the presence of nearly equal quantities of template RNA was con®rmed by RT ± PCR experiments on the HPRT gene (data not shown).
Discussion
In this study we have described the comprehensive isolation and identi®cation of CpG islands that are methylated in human lung adenocarcinoma. A major consequence of this de novo methylation of CpG islands is the possible transcriptional repression of the associated gene. Indeed, in our study we have con®rmed that some genes that are inactivated and associated with CpG island methylation are reactivated by demethylation and histone deacetylation, suggesting that methylation is a cause of silencing. Therefore we believe that of the inactivated genes with CpG island methylation, a number will be novel tumor suppressor genes. For example, CpG island B2254 is derived from the HOXA5 gene whose gene product positively regulates the expression of the TP53 tumor suppressor gene (Raman et al., 2000) . It has been reported that this gene is inactivated by CpG methylation in human breast cancer (Raman et al., 2000) . A tumorsuppressive role for the SFRP1 gene in human breast cancer has also been reported recently (Ugolini et al., 2001) . The SFRP1 gene product is a member of Secreted Frizzled-Related Protein family and one of its members, SFRP2 (B2878 in Table 1 ), has been isolated in our study. These results would also strongly imply that the SFRP2 gene product has a tumor-suppressor role. As our investigation has lead to the isolation of CpG island fragments from known, and candidate, tumor suppressor genes it is likely that a number of the other isolated fragments will correspond to previously unidenti®ed lung tumor suppressor genes.
As yet the exact number of CpG islands in the human genome is unknown. On the basis of sensitivity to HpaII digestion, Antequera and Bird (1993) have estimated that there are 45 000 CpG islands in the haploid human genome. However, based on CpG density, a ®gure of 29 000 CpG islands has been suggested (Venter et al., 2001; International Human Genome Sequencing Consortium, 2001 ) (although the methylation status of these sequences has yet to be determined). Costello et al. (2000) analysed aberrant CpG islands in human cancer by restriction landmark genomic scanning and found the number of methylated CpG islands to be between zero and 4500 assuming 45 000 CpG islands in the human genome, depending on the patient. This provides an average of approximately 600. A similar ®gure has been also reported in their subsequent work (Dai et al., 2001 ). In our study, the number of methylated CpG islands isolated per patient was between 24 and 138. The dierences between patients could be attributed to the CpG island methylator phenotype as reported in colon cancer (Toyota et al., 1999) or heterogeneity in subtypes of lung adenocarcinomas. Since we are unsure how many methylated CpG islands are contained in the original library, we cannot estimate the total number of methylated CpG islands in each patient's DNA. However, most randomly selected CpG islands were methylation free (Figure 4 and data not shown) (except for patients 113 and 116) and we believe that most of the highly represented CpG islands in the library have been identi®ed. Therefore we can estimate the average number of methylated CpG islands in human lung adenocarcinomas to be approximately several hundred (1 ± 2% of the total number of CpG islands). Fourteen of the CpG islands identi®ed did not have tumorspeci®c methylation. Isolation of these fragments could be accidental contamination or overrepresentation of DNA fragments that were methylated in only a limited population of cancer cells.
In our analysis we found that some aberrant methylation was not tumor-speci®c and also observed in DNA derived from noncancerous portions of lung tissue (Figure 2b) . However, methylation of each CpG island in noncancerous portions of the lung did not occur in all patients. These results suggest that methylation of these CpG islands is not an intrinsic, developmentally programmed event, but a de novo event. The incremental dierences in methylation between patients may be an event associated with aging (Issa et al., 1994; Ahuja et al., 1998) or a Figure 4 Bisul®te genomic sequencing analysis of the DNA fragments derived from the 3' CpG island B1847 (PAX1). Symbols are identical to those used in Figure 3 Comprehensive isolation of methylated CpG islands M Shiraishi et al Recently it has also been suggested that dierent CpG islands have dierent susceptibility to de novo methylation (Nguyen et al., 2001) . Methylation of CpG islands was not restricted to genes expressed in lung tissue. Some CpG islands of genes such as the PKDREJ (B178), which is exclusively expressed in testis (Hughes et al., 1999) , and the arginine vasopressin receptor 1A (AVPR1A) gene (B762), which is not expressed in lung tissue (Thibonnier et al., 1996) , were also methylated in many patients (Table 1) . Apparently these examples of de novo methylation are not associated with transcrip- tional repression. CpG islands associated with cDNAs FLJ20699 and FLJ10140 are located near the PKDREJ locus, but in all patients the genes represented by these cDNAs were unmethylated (data not shown). These results demonstrate that methylation of the PKDREJ CpG island was not a consequence of an indiscriminate wave of regional island methylation. The elucidation of the molecular mechanism and signi®cance of de novo methylation of the CpG island in nonexpressed genes requires further study. However, it has recently been reported that DNA methylation mediated by DNMT1 is associated with histone acetylation and altered chromatin structure (Fuks et al., 2000; Rountree et al., 2000; Robertson et al., 2000) . Furthermore, in Neurospora crassa, DNA methylation has been shown to depend on histone methylation (Tamaru and Selker, 2001 ). Therefore methylation of CpG islands of nonexpressed genes may be a consequence of altered histone modi®cation that regulates chromatin structure.
In summary, we have produced a catalog of CpG islands that are speci®cally methylated in human lung adenocarcinomas. We believe that this catalog will be an invaluable resource for the elucidation of epigenetic processes in carcinogenesis.
Materials and methods
Methylated DNA library and SPM analysis
Construction of the library of methylated DNA derived from nine male lung adenocarcinoma patients was performed as previously reported (Shiraishi et al., 1999a ). The original library, which was constructed from a mixture of tumor DNAs from nine male lung adenocarcinoma patients (ages ranging from 52 to 76) and contained 3610 5 plaque forming units (pfu), was ampli®ed to 5610 11 pfu and then an aliquot of the ampli®ed library (1.5610 8 pfu) plus helper phage ExAssist (1.5610 9 pfu, Stratagene) were used to coinfect to XL1-Blue MRF' cells (3610 8 cells). After a short period of culture, heat-treated supernatant was incubated with SOLR cells (suspension in 20 mM MgSO 4 solution from 20 ml of overnight culture) and spread on sixteen 2436243 mm plates for conversion to phagemid clones (2610 9 colony forming units). The conversion procedure was performed using a published protocol (Short and Sorge, 1992 ) with slight modi®cations. All colonies on plates were harvested by gently scraping into a small volume of medium (30 ml per plate) and subjected to overnight culture. Phagemid DNAs were prepared and puri®ed by two rounds of equilibrium centrifugation in CsCl-ethidium bromide gradients. After AseI digestion of the phagemid DNAs and DNA fragments longer than 2 kb (by preparative agarose gel electrophoresis) were isolated. Twenty mg of recovered fragments were digested with Tsp509 I, MseI, and NlaIII, and the DNA was recovered using GENECLEAN KIT (BIO 101). One third of the recovered fragments were subjected to denaturing gradient gel electrophoresis as described previously (Shiraishi et al., 1995 (Shiraishi et al., , 1998 (Shiraishi et al., , 1999a . As the amount of DNA retained in the gel was not sucient to be detected by ethidium bromide staining, the bottom half of the gel was excised and DNA fragments were recovered as previously described (Shiraishi et al., 1995) . The bottom 10% of the gel was then discarded to avoid contamination of dissociated single-stranded DNA. Fifty per cent of the recovered fragments were ligated with a mixture of EcoRI, NdeI, SphI, EcoRI/NdeI, EcoRI/SphI, and NdeI/SphI digests of pKF3 (TaKaRa) and electroporated into the bacterial strain TH2 (Hashimoto-Gotoh et al., 1993) . Plasmid DNA was prepared from each colony and subjected to nucleotide sequence analysis of a single DNA strand. Similarity searches were performed using websites (http://www.ncbi. nlm. nih. gov / blast / blast.cgi, http://www.ncbi.nlm. nih.gov/genome/seq/ HsBlast.html, http://spiral.genes.nig.ac.jp/homology/blaste.shtml). The algorithm at website (http://www.ebi.ac.uk/ cpg/ and/or http://www.ebi.ac.uk/emboss/cpgplot/) was used to detect potential CpG islands. An aliquot of the ampli®ed library is available upon request.
Analysis of the methylation status by MBD column chromatography
Ten mg of high molecular weight DNA from normal submandibular glands (MaN) and that from the cell line Lu65 (puri®ed by equilibrium centrifugation in CsCl gradients) were digested with 30 units of Tsp509 I (New England Biolabs) following the manufacturer's recommendations. After phenol-chloroform extraction and precipitation, the recovered digests were analysed separately using the same MBD column as described previously (Shiraishi et al., 1999a ). An aliquot from each fraction was subjected to PCR to detect DNA fragments containing a CpG island of the CDH1 gene as described previously (Shiraishi et al., 1999a) . The CDH1 CpG island is not methylated in MaN DNA (Shiraishi et al., 1999a) and methylated in Lu65 DNA (Yoshiura et al., 1995) . MaN fractions containing the DNA fragment corresponding to the nonmethylated CDH1 CpG island and those corresponding to the fractions containing the methylated CDH1 CpG island in Lu65 DNA were classi®ed as low salt (L) and high salt (H) fractions, respectively. The absolute salt concentration at the boundary can dier between experiments since the retention capacity of the column decreases after extensive use, and its determination requires calibration using appropriate standard DNA. DNAs from surgical specimens (Shiraishi et al., 1989) and cell lines had been already fractionated as described previously (Shiraishi et al., 1999a) . Further information on PCR conditions and primer sequences is available upon request.
Bisulfite genomic sequencing experiments
Bisul®te modi®cation of Tsp509 I digests of genomic DNA was performed following a published procedure (Frommer et Figure 5 Analysis of the methylation status of CpG islands and the expression of associated genes in cultured cells. DNAs were analysed by MBD column chromatography and PCR. Total RNA was analysed by RT ± PCR. RT ± PCR reactions were performed in the presence (+) or absence (7) of reverse transcriptase, respectively 
RT ± PCR experiments
Total RNA from cultured cells was extracted with TriPure Isolation Reagent (Boehringer Mannheim). Three mg of total RNA was incubated with random hexamer oligodeoxynucleotides (Gibco ± BRL). Half of the mixture was treated with M-MLV reverse transcriptase (Gibco ± BRL) following the manufacturer's recommendation (RT+). The other half was used as negative control (RT7). One twentieth of each reaction mixture was used as template for PCR. Further information on PCR conditions and primer sequences is available upon request.
